Terms: = Bone cancer AND MYCN, N-myc, 4613, ENSG00000134323, NMYC, MODED, ODED
248 results:
1. Partial Response to Naxitamab for Brain Metastasis in Neuroblastoma.
Onyeukwu C; Williams A; Seyboth B; Muñoz L; Scaria G; Kent P
J Pediatr Hematol Oncol; 2024 Mar; 46(2):e188-e190. PubMed ID: 38189408
[TBL] [Abstract] [Full Text] [Related]
2. Pediatric neuroblastoma with intraspinal extension: the role of surgical management.
Chang D; Oh T; Roland JL; Matthay KK; Vo KT; Edwards CS; Sun PP; Auguste KI; Gupta N
J Neurosurg Pediatr; 2024 Mar; 33(3):245-255. PubMed ID: 38100763
[TBL] [Abstract] [Full Text] [Related]
3. Activating Transcription Factor 5 Promotes Neuroblastoma Metastasis by Inducing Anoikis Resistance.
Banerjee D; Boboila S; Okochi S; Angelastro JM; Kadenhe-Chiweshe AV; Lopez G; Califano A; Connolly EP; Greene LA; Yamashiro DJ
Cancer Res Commun; 2023 Dec; 3(12):2518-2530. PubMed ID: 38014922
[TBL] [Abstract] [Full Text] [Related]
4. Mouse models of pediatric high-grade gliomas with mycn amplification reveal intratumoral heterogeneity and lineage signatures.
Schoof M; Godbole S; Albert TK; Dottermusch M; Walter C; Ballast A; Qin N; Olivera MB; Göbel C; Neyazi S; Holdhof D; Kresbach C; Peter LS; Epplen GD; Thaden V; Spohn M; Blattner-Johnson M; Modemann F; Mynarek M; Rutkowski S; Sill M; Varghese J; Afflerbach AK; Eckhardt A; Münter D; Verma A; Struve N; Jones DTW; Remke M; Neumann JE; Kerl K; Schüller U
Nat Commun; 2023 Nov; 14(1):7717. PubMed ID: 38001143
[TBL] [Abstract] [Full Text] [Related]
5. Targeted Degradation of XIAP is Sufficient and Specific to Induce Apoptosis in mycn-overexpressing High-risk Neuroblastoma.
Choo Z; Koh X; Wong MRE; Ashokan RM; Ali Ahamed NSB; Kang C; Kuick CH; Chang KTE; Larisch S; Loh AHP; Chen ZX
Cancer Res Commun; 2023 Nov; 3(11):2386-2399. PubMed ID: 37874199
[TBL] [Abstract] [Full Text] [Related]
6. Posttreatment complications in pediatric cervical neuroblastoma: A retrospective case series at a tertiary cancer center.
Lopez J; Subramanian T; Durell J; Levyn H; Wong R; Shah J; LaQuaglia MP; Gerstle JT
J Surg Oncol; 2024 Feb; 129(2):219-223. PubMed ID: 37850570
[TBL] [Abstract] [Full Text] [Related]
7. Stage 4N neuroblastoma before and during the era of anti-G
Kushner BH; LaQuaglia MP; Cardenas FI; Basu EM; Gerstle JT; Kramer K; Roberts SS; Wolden SL; Cheung NV; Modak S
Int J Cancer; 2023 Dec; 153(12):2019-2031. PubMed ID: 37602920
[TBL] [Abstract] [Full Text] [Related]
8. Adaptation of the Th-mycn Mouse Model of Neuroblastoma for Evaluation of Disseminated Disease.
Rahavi SM; Aletaha M; Farrokhi A; Lorentzian A; Lange PF; Maxwell CA; Lim CJ; Reid GSD
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569447
[TBL] [Abstract] [Full Text] [Related]
9. Successful all robotic-assisted excision of highly malignant mediastinal neuroblastoma in a toddler: A case report.
Ochi T; Koga H; Ueno H; Fujimura J; Kosaka S; Miyake Y; Yoshida S; Lane GJ; Suzuki K; Yamataka A
Asian J Endosc Surg; 2023 Jul; 16(3):542-545. PubMed ID: 36882918
[TBL] [Abstract] [Full Text] [Related]
10. Amplification of CDK4 and MDM2: a detailed study of a high-risk neuroblastoma subgroup.
Martinez-Monleon A; Kryh Öberg H; Gaarder J; Berbegall AP; Javanmardi N; Djos A; Ussowicz M; Taschner-Mandl S; Ambros IM; Øra I; Sandstedt B; Beiske K; Ladenstein R; Noguera R; Ambros PF; Gordon Murkes L; Ljungman G; Kogner P; Fransson S; Martinsson T
Sci Rep; 2022 Jul; 12(1):12420. PubMed ID: 35859155
[TBL] [Abstract] [Full Text] [Related]
11. Isolated central nervous system relapses in patients with high-risk neuroblastoma -clinical presentation and prognosis: experience of the Polish Paediatric Solid Tumours Study Group.
Wieczorek A; Stefanowicz J; Hennig M; Adamkiewicz-Drozynska E; Stypinska M; Dembowska-Baginska B; Gamrot Z; Woszczyk M; Geisler J; Szczepanski T; Skoczen S; Ussowicz M; Pogorzala M; Janczar S; Balwierz W
BMC Cancer; 2022 Jun; 22(1):701. PubMed ID: 35752779
[TBL] [Abstract] [Full Text] [Related]
12. The immune landscape of solid pediatric tumors.
Sherif S; Roelands J; Mifsud W; Ahmed EI; Raynaud CM; Rinchai D; Sathappan A; Maaz A; Saleh A; Ozer E; Fakhro KA; Mifsud B; Thorsson V; Bedognetti D; Hendrickx WRL
J Exp Clin Cancer Res; 2022 Jun; 41(1):199. PubMed ID: 35690832
[TBL] [Abstract] [Full Text] [Related]
13. Immune contexture of paediatric cancers.
Thakur MD; Franz CJ; Brennan L; Brouwer-Visser J; Tam R; Korski K; Koeppen H; Ziai J; Babitzki G; Ranchere-Vince D; Vasiljevic A; Dijoud F; Marec-Bérard P; Rochet I; Cannarile MA; Marabelle A
Eur J Cancer; 2022 Jul; 170():179-193. PubMed ID: 35660252
[TBL] [Abstract] [Full Text] [Related]
14. Neuroblastoma: Essential genetic pathways and current therapeutic options.
Salemi F; Alam W; Hassani MS; Hashemi SZ; Jafari AA; Mirmoeeni SMS; Arbab M; Mortazavizadeh SMR; Khan H
Eur J Pharmacol; 2022 Jul; 926():175030. PubMed ID: 35605657
[TBL] [Abstract] [Full Text] [Related]
15. mycn amplification plus 1p36 loss of heterozygosity predicts ultra high risk in bone marrow metastatic neuroblastoma.
Yue ZX; Xing TY; Zhao W; Zhao Q; Wang XS; Su Y; Gao C; Liu SG; Ma XL
Cancer Med; 2022 Apr; 11(8):1837-1849. PubMed ID: 35137546
[TBL] [Abstract] [Full Text] [Related]
16. Clinically aggressive pediatric spinal ependymoma with novel MYC amplification demonstrates molecular and histopathologic similarity to newly described mycn-amplified spinal ependymomas.
Shatara M; Schieffer KM; Klawinski D; Thomas DL; Pierson CR; Sribnick EA; Jones J; Rodriguez DP; Deeg C; Hamelberg E; LaHaye S; Miller KE; Fitch J; Kelly B; Leraas K; Pfau R; White P; Magrini V; Wilson RK; Mardis ER; Abdelbaki MS; Finlay JL; Boué DR; Cottrell CE; Ghasemi DR; Pajtler KW; Osorio DS
Acta Neuropathol Commun; 2021 Dec; 9(1):192. PubMed ID: 34895332
[TBL] [Abstract] [Full Text] [Related]
17. Pediatric Extraspinal Subcutaneous Sacrococcygeal Myxopapillary Ependymoma: Case Report and Minireview.
Liu Y; Peng Y; Wang X; Guo Z; Xiang C; Wan W; Wang X; Hu Y
Am J Dermatopathol; 2021 Dec; 43(12):e273-e276. PubMed ID: 34797808
[TBL] [Abstract] [Full Text] [Related]
18. Evaluation of circulating Dickkopf-1 as a prognostic biomarker in ovarian cancer patients.
Klotz DM; Link T; Goeckenjan M; Wimberger P; Poetsch AR; Jaschke N; Hofbauer LC; Göbel A; Rachner TD; Kuhlmann JD
Clin Chem Lab Med; 2022 Jan; 60(1):109-117. PubMed ID: 34687595
[TBL] [Abstract] [Full Text] [Related]
19. The Significance of Histopathologic Assessment in bone Marrow Disease in Neuroblastoma.
Ekmekci S; Ince D; Olgun N; Ozer E
Turk Patoloji Derg; 2022; 38(2):99-105. PubMed ID: 34558657
[TBL] [Abstract] [Full Text] [Related]
20. In vivo evaluation of the lysine-specific demethylase (KDM1A/LSD1) inhibitor SP-2577 (Seclidemstat) against pediatric sarcoma preclinical models: A report from the Pediatric Preclinical Testing Consortium (PPTC).
Kurmasheva RT; Erickson SW; Han R; Teicher BA; Smith MA; Roth M; Gorlick R; Houghton PJ
Pediatr Blood Cancer; 2021 Nov; 68(11):e29304. PubMed ID: 34453478
[TBL] [Abstract] [Full Text] [Related]
[Next]
